SaxoTV

Berger: Biotech ETFs bubbling higher

347 views
May 28, 2015 bio tech, bio tech stocks, bio technology, biotech, biotech bubble, biotech companies, biotech etf, biotech stock, biotech stocks, bull market, bullish, bullish sentiment, equities, equities prices, equities saxo, equities strength, equities trading, equity, equity index, equity market, equity markets, equity portfolio, equity portfolios, equity research, equity strategy, equity trading, equity us, etf, etf fund, etf investment, etf portfolio, etf trading, etfs, ishares nasdaq biotechnology, saxo, saxo bank, saxo bank equities, saxo bank group, saxo bank saxo tv, saxo bank trading, saxo bank trading floor, saxo bank tradingfloor.com, saxo bank tv, saxo traders, saxo trading, saxo tv, saxo tv saxo bank, saxo tv trades, saxo tv trading, saxo tv trading floor, saxo tv tradingfloor, saxo tv tradingfloor.com, saxobank, saxotrader, saxotv, serge berger, serge berger tradingfloor.com, stock, stock market, stock markets, stock picks, stock price, stock prices, stock rise, stock trading, stocks, stocks markets, stocks to watch, trade, trade idea, trade ideas, trade view, trader, traders, traders tale, traders tale saxo tv, traders tale serge berger, trades, trading, trading floor, trading floor saxo tv, trading idea, trading risks, trading strategy, trading tips, tradingfloor, tradingfloor saxo bank, tradingfloor saxo tv, tradingfloor.com, tradingfloor.com insights, tradingfloor.com saxo tv, tradingfloor.com trade ideas, tradingfloorcom
The massive rally in the biotechnology sector is not over according to Serge Berger, also known as The Steady Trader. Serge is interested in investing in the iShares Nasdaq Biotechnology ETF (IBB), which is up 20% year-to-date. Although the industry has seen tremendous growth, not all companies are seeing equal growth, which is why Serge is investing an ETF. The iShares Nasdaq Biotechnology ETF (IBB) and the SPDR S&P Biotech ETF are the two largest ETFs in biotech. Given both the relative and absolute strength seen in the biotech sector over the past month, there is still potential for one more break higher according to Serge. Therefore, he is looking to buy the biotech ETF at USD 366.50 with a target of USD 385. A stop can be placed at USD 354.

Join the conversation below to be a part of the social trading experience.

Non-independent investment research disclaimer

Full disclaimer